Vanguard Group Inc Terns Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,356,814 shares of TERN stock, worth $19.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,356,814

Previous 2,300,942 45.89%

Holding current value

$19.5 Million

Previous $15.7 Million 78.66%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.49 - $10.8 $6.85 Million - $11.4 Million	1,055,872 Added 45.89%	3,356,814 $28 Million
Q2 2024 Aug 13, 2024	BUY	$4.54 - $8.2 $462,789 - $835,875	101,936 Added 4.64%	2,300,942 $15.7 Million
Q1 2024 May 10, 2024	BUY	$4.86 - $8.19 $56,060 - $94,471	11,535 Added 0.53%	2,199,006 $14.4 Million
Q4 2023 Feb 14, 2024	SELL	$3.37 - $6.86 $49,346 - $100,450	-14,643 Reduced 0.66%	2,187,471 $14.2 Million
Q3 2023 Nov 14, 2023	SELL	$4.7 - $8.55 $108,837 - $197,992	-23,157 Reduced 1.04%	2,202,114 $11.1 Million
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.29 $6.87 Million - $12.4 Million	934,022 Added 72.33%	2,225,271 $19.5 Million
Q1 2023 May 15, 2023	BUY	$7.91 - $12.0 $1.31 Million - $1.98 Million	165,213 Added 14.67%	1,291,249 $15.3 Million
Q4 2022 Feb 10, 2023	BUY	$4.62 - $10.18 $2.34 Million - $5.16 Million	506,904 Added 81.87%	1,126,036 $11.5 Million
Q3 2022 Nov 14, 2022	BUY	$1.87 - $6.42 $470,497 - $1.62 Million	251,603 Added 68.46%	619,132 $3.65 Million
Q2 2022 Aug 12, 2022	SELL	$1.5 - $3.0 $98,235 - $196,470	-65,490 Reduced 15.12%	367,529 $912,000
Q1 2022 May 13, 2022	SELL	$2.83 - $6.7 $354,621 - $839,563	-125,308 Reduced 22.44%	433,019 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$5.65 - $10.73 $664,750 - $1.26 Million	117,655 Added 26.7%	558,327 $3.95 Million
Q3 2021 Nov 12, 2021	BUY	$7.22 - $13.46 $180,081 - $335,719	24,942 Added 6.0%	440,672 $4.59 Million
Q2 2021 Aug 13, 2021	BUY	$12.26 - $22.0 $5.1 Million - $9.15 Million	415,730 New	415,730 $5.1 Million

Others Institutions Holding TERN

# of Institutions

167

Shares Held

78.3M

Call Options Held

580K

Put Options Held

454K

View Full List

About Terns Pharmaceuticals, Inc.

Ticker TERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,613,800
Market Cap $218M
Description
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...

More about TERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Terns Pharmaceuticals, Inc. Transaction History